ebv1s8rn | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/ebv1s8rn_hasAnnotation_C1418948>
?:creator	<https://research.tib.eu/covid-19/entity/Zhao%2C_Tie%3B_Peng%2C_Liang>
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.dsx.2020.11.017>
?:doi	10.1016/j.dsx.2020.11.017
?:journal	Diabetes_Metab_Syndr
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/d8d93041d5824c3bb530cd02c690832b524d2b04.json
?:pmc_json_files	document_parses/pmc_json/PMC7687361.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7687361>
?:pmid	<https://research.tib.eu/covid-19/entity/33279832.0>
?:pmid	33279832.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/d8d93041d5824c3bb530cd02c690832b524d2b04>
?:source	Elsevier; Medline; PMC
?:title	Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.)
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-25

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/ebv1s8rn>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/ebv1s8rn>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all